Objective: To study the correlation between serum and urine hCG levels in gestational trophoblastic disease (GTD) patients with low hCG level. The correlation between serum hCG and results from urine pregnancy tests are evaluated along with quantitative measurement.
Material And Method: In this prospective study, 86 cases of gestational trophoblastic disease patients with positive and low level of serum hCG (< 100 mIU/ml) were recruited. Quantitative serum hCG urine hCG and urine pregnancy test were performed. The correlation coefficients between serum and urine hCG were then analyzed by SPSS 16.0. Furthermore, the levels of serum hCG were compared to the results of the urine pregnancy test.
Results: From February 2006 to June 2008, 86 cases were recruited for this study. The correlation coefficient between serum and urine hCG levels in all cases was 0.44 (using Pearson correlation), p = 0.01. In subgroup analysis, the correlation coefficient between serum and urine hCG levels in chemosensitive gestational trophoblastic neoplasia (GTN) patients (n = 27) was 0.73, p ≤ 0.01. The correlation coefficient in chemoresistant GTN patients (n = 38) was 0.29, p = 0.07; and the correlation coefficient in hydatidiform mole patients (n = 21) was 0.47, p = 0.03. A urine pregnancy test was positive only in 10 of 86 specimens.
Conclusion: The correlation coefficient between serum and urine hCG in GTD patients with low hCG level showed significant correlation. However, patients with chemoresistance had less correlation than those with chemosensitivity and hydatidiform mole. Urine pregnancy test had low correlation with urine hCG and was not useful in this group of patients.
Download full-text PDF |
Source |
---|
BMJ Case Rep
January 2025
Division of Hematology and Oncology, University of California San Francisco, San Francisco, California, USA
Secretion of beta human chorionic gonadotropin (β-hCG) is a rare, recently recognised paraneoplastic syndrome. Herein, we present a case of a woman in her 30s with right femur conventional high-grade osteosarcoma and a positive screening urine pregnancy test. Subsequent workup failed to reveal an intrauterine or extrauterine pregnancy.
View Article and Find Full Text PDFAm J Transl Res
November 2024
Department of Gynaecology and Obstetrics, General Global China Railway Xi'an Hospital No. 319, East Section of South Second Ring Road, Beilin District, Xi'an 710000, Shaanxi, China.
Objective: To investigate the predictive value of placental growth factor (PlGF) for adverse pregnancy outcome in twin pregnancies at advanced maternal age.
Methods: A retrospective analysis was conducted on 387 women with twin pregnancies who delivered at Northwest Women's and Children's Hospital between March 2020 and March 2024. The women were divided into a favorable outcome group (n = 249) and an adverse outcome group (n = 138) based on their pregnancy outcome.
Cureus
November 2024
Emergency Medicine, University of Florida College of Medicine, Gainesville, USA.
The detection of ectopic pregnancy (EP) by point-of-care ultrasound has become an integral competency of emergency medicine practice. Clinical algorithms usually include a female of childbearing age, positive urine or serum human chorionic gonadotropin (hCG) test, and an ultrasound evaluation to assess the presence or absence of intrauterine pregnancy. This case report illustrates incidental findings observed during focused assessment with sonography in trauma (FAST examination), which initially suggested an intra-ovarian EP.
View Article and Find Full Text PDFBMJ Open
November 2024
Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
Ann Clin Lab Sci
September 2024
Department of Pathology and Laboratory Medicine, Women & Infants Hospital, Providence, RI, USA
Objective: We report the first documented case of concurrent ectopic complete hydatidiform mole (CHM) and high-grade serous carcinoma (HGSC) of the fallopian tube, associated with unique histologic features and mutations in the HGSC.
Case Report: The patient presented with pelvic pain and vaginal bleeding. Laboratory examination revealed a positive urine pregnancy test and high serum beta-human chorionic gonadotropin (β-hCG).
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!